2002•Zhonghua shiyan waike zazhiRequires access

Expression of prostatic specific membrane antigen and prostatic specific antigen in prostatic adenocarcinoma tissue

Weiping Liu

Open publisher page 0 citations

Abstract

Objective To observe and compare the expression difference of prostatic specific membrane antigen (PSMA) and prostatic specific antigen (PSA) in different prostatic tissues and compare the roles of PSMA and PSA in the diagnosis of prostate adenocarcinoma.Methods Seventy cases of prostate adenocarcinoma,21 cases of prostatic intraepithelial neoplasms and 20 cases of benign prostatic hyperplasia were analyzed for the expression of PSMA and PSA with PSMA monoclonal antibody and PSA monoclonal antibody by using ABC immunohistochemical staining.Results High expression of PSMA was detected in prostatic adenocarcinoma tissues,while high expression of PSA was detected in benign prostatic hyperplasia;Positive ratio of PSMA expression was obviously higher than that of PSA in prostatic adenocarinoma.Conclusion PSMA may be a more specific marker for prostatic tumor than PSA and could substituted for PSA as a novel marker for the diagnosis of prostatic adenocarcinoma.

About this research paper

What this paper is about

Objective To observe and compare the expression difference of prostatic specific membrane antigen (PSMA) and prostatic specific antigen (PSA) in different prostatic tissues and compare the roles of PSMA and PSA in the diagnosis of prostate adenocarcinoma.Methods Seventy cases of prostate adenocarcinoma,21 cases of prostatic intraepithelial neoplasms and 20 cases of benign prostatic hyperplasia were analyzed for the expression of PSMA and PSA with PSMA monoclonal antibody and PSA monoclonal antibody by using ABC immunohistochemical staining.Results High expression of PSMA was detected in prostatic adenocarcinoma tissues,while high expression of PSA was detected in benign prostatic hyperplasia;Positive ratio of PSMA expression was obviously higher than that of PSA in prostatic adenocarinoma.Conclusion PSMA may be a more specific marker for prostatic tumor than PSA and could substituted for PSA as a novel marker for the diagnosis of prostatic adenocarcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe and compare the expression difference of prostatic specific membrane antigen (PSMA) and prostatic specific antigen (PSA) in different prostatic tissues and compare the roles of PSMA and PSA in the diagnosis of prostate adenocarcinoma.Methods Seventy cases of prostate adenocarcinoma,21 cases of prostatic intraepithelial neoplasms and 20 cases of benign prostatic hyperplasia were analyzed for the expression of PSMA and PSA with PSMA monoclonal antibody and PSA monoclonal antibody by using ABC immunohistochemical staining.Results High expression of PSMA was detected in prostatic adenocarcinoma tissues,while high expression of PSA was detected in benign prostatic hyperplasia;Positive ratio of PSMA expression was obviously higher than that of PSA in prostatic adenocarinoma.Conclusion PSMA may be a more specific marker for prostatic tumor than PSA and could substituted for PSA as a novel marker for the diagnosis of prostatic adenocarcinoma.

Key concepts: Hyperplasia, Immunohistochemistry, Intraepithelial neoplasia, Medicine, Glutamate carboxypeptidase II, Antigen, Prostate, Prostatic adenocarcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of prostatic specific membrane antigen and prostatic specific antigen in prostatic adenocarcinoma tissue — Research Paper | ScholarLens